Literature DB >> 26327249

Arglabin: From isolation to antitumor evaluation.

Shabir H Lone1, Khursheed A Bhat2, Mohd A Khuroo3.   

Abstract

Arglabin belongs to guaianolide class of sesquiterpene lactones, isolated from Artemisia species. The molecule bears a 5,7,5-tricyclic ring system having five contiguous stereo centers in which the two five membered rings are trans-annulated. Arglabin shows promising antitumor activity against different tumor cell lines. The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors. It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase). The present review is an attempt to summarize the chemistry and biology of this molecule since its isolation in 1982. It embodies the isolation, structure elucidation, stereo chemical description, structural classification, chemical synthesis, structural modifications and antitumor evaluation reported till date.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antitumor; Arglabin; Farnesyl transferase; Guaianolide; Isolation; Synthesis

Mesh:

Substances:

Year:  2015        PMID: 26327249     DOI: 10.1016/j.cbi.2015.08.015

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  13 in total

Review 1.  Catalytic Asymmetric Synthesis of Butenolides and Butyrolactones.

Authors:  Bin Mao; Martín Fañanás-Mastral; Ben L Feringa
Journal:  Chem Rev       Date:  2017-06-22       Impact factor: 60.622

Review 2.  Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.

Authors:  Daniela Carlisi; Marianna Lauricella; Antonella D'Anneo; Anna De Blasio; Adriana Celesia; Giovanni Pratelli; Antonietta Notaro; Giuseppe Calvaruso; Michela Giuliano; Sonia Emanuele
Journal:  Biomedicines       Date:  2022-02-21

3.  Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma.

Authors:  Jin-Jin Sun; Jin-Ping Wang; Tian-Ze Li; Yun-Bao Ma; Dong Xue; Ji-Jun Chen
Journal:  Med Chem Res       Date:  2022-05-24       Impact factor: 2.351

4.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

5.  Sesquiterpene Lactones and Flavonoids from Psephellus pyrrhoblepharus with Antiproliferative Activity on Human Gynecological Cancer Cell Lines.

Authors:  Pelin Tastan; Zsuzsanna Hajdú; Norbert Kúsz; István Zupkó; Izabella Sinka; Bijen Kivcak; Judit Hohmann
Journal:  Molecules       Date:  2019-08-30       Impact factor: 4.411

6.  Artemyrianins A-G from Artemisia myriantha and Their Cytotoxicity Against HepG2 Cells.

Authors:  Shuang Tang; Yun-Bao Ma; Chang-An Geng; Cheng Shen; Tian-Ze Li; Xue-Mei Zhang; Li-Hua Su; Zhen Gao; Jing Hu; Ji-Jun Chen
Journal:  Nat Prod Bioprospect       Date:  2020-06-28

7.  Isolation and Characterization of Methylated Flavones from Artemisia kermanensis.

Authors:  Zeinab Yazdiniapour; Afsaneh Yegdaneh; Soudeh Akbari
Journal:  Adv Biomed Res       Date:  2021-09-29

8.  Diversity Modification and Structure-Activity Relationships of Two Natural Products 1β-hydroxy Alantolactone and Ivangustin as Potent Cytotoxic Agents.

Authors:  Jiang-Jiang Tang; Qiu-Rui He; Shuai Dong; Xin Guo; Yu-Gong Wang; Bei-Lei Lei; Jun-Mian Tian; Jin-Ming Gao
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  EMP1 Promotes the Proliferation and Invasion of Ovarian Cancer Cells Through Activating the MAPK Pathway.

Authors:  Yang Liu; Yiling Ding; Yanting Nie; Mengyuan Yang
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

Review 10.  Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents.

Authors:  Asim Najmi; Sadique A Javed; Mohammed Al Bratty; Hassan A Alhazmi
Journal:  Molecules       Date:  2022-01-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.